RELATIVE EFFECTIVENESS OF FARICIMAB VS AFLIBERCEPT 8 MG AFTER LOADING PHASE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND DIABETIC MACULAR EDEMA

被引：0
|
作者：
Buhrer, C. [1 ]
Tabano, D. [2 ]
Cox, O. [1 ]
机构：
[1] F Hoffmann Roche, Basel, Switzerland
[2] Genentech Inc, South San Francisco, CA USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO187
引用
收藏
页码：S47 / S47
页数：1
相关论文
共 50 条
  • [1] Aflibercept versus Faricimab in the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Review
    Liberski, Slawomir
    Wichrowska, Malgorzata
    Kociecki, Jaroslaw
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)
  • [2] Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
    Desideri, Lorenzo Ferro
    Traverso, Carlo Enrico
    Nicolo, Massimo
    Munk, Marion R.
    [J]. PHARMACEUTICS, 2023, 15 (05)
  • [3] ECONOMIC BENEFIT OF FARICIMAB COMPARED TO AFLIBERCEPT 8MG IN TREATING PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION OR DIABETIC MACULAR EDEMA IN THE UNITED STATES
    Tabano, D.
    El Moustaid, F.
    Rosettie, K. L.
    Ko, S.
    Meer, E.
    Brodie, F. L.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S61 - S61
  • [4] Comparison of Loading Dose between Aflibercept and Faricimab for Neovascular Age-Related Macular Degeneration
    Hara, Chikako
    Suzue, Masaki
    Fujimoto, Satoko
    Fukushima, Yoko
    Sayanagi, Kaori
    Nishida, Kentaro
    Maruyama, Kazuichi
    Sato, Shigeru
    Nishida, Kohji
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (02)
  • [5] Faricimab (Vabysmo) for Age-Related Macular Degeneration and Diabetic Macular Edema
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2022, 64 (1646): : 45 - 46
  • [6] Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes
    Agostini, Hansjuergen
    Abreu, Francis
    Baumal, Caroline R.
    Chang, Dolly S.
    Csaky, Karl G.
    Demetriades, Anna M.
    Kodjikian, Laurent
    Lim, Jennifer I.
    Margaron, Philippe
    Mones, Jordi M.
    Peto, Tunde
    Ricci, Federico
    Rueth, Matthias
    Singh, Rishi P.
    Stoilov, Ivaylo
    Swaminathan, Balakumar
    Willis, Jeffrey R.
    Westenskow, Peter D.
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024,
  • [7] Quantitative response of macular neovascularisation to loading phase of aflibercept in neovascular age-related macular degeneration
    Andrea Montesel
    Ahmed M. Hagag
    Shruti Chandra
    Raheeba Pakeer Muhammed
    Sridevi Thottarath
    Swati Chandak
    Sobha Sivaprasad
    [J]. Eye, 2023, 37 : 3648 - 3655
  • [8] Quantitative response of macular neovascularisation to loading phase of aflibercept in neovascular age-related macular degeneration
    Montesel, Andrea
    Hagag, Ahmed M.
    Chandra, Shruti
    Muhammed, Raheeba Pakeer
    Thottarath, Sridevi
    Chandak, Swati
    Sivaprasad, Sobha
    [J]. EYE, 2023, 37 (17) : 3648 - 3655
  • [9] Real-World Outcomes of Faricimab Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
    Quah, Nicole Q. X.
    Javed, Khawaja Muhammad Ammar Ali
    Arbi, Lamees
    Hanumunthadu, Daren
    [J]. CLINICAL OPHTHALMOLOGY, 2024, 18 : 1479 - 1490
  • [10] ENVIRONMENTAL IMPACT OF AFLIBERCEPT FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND DIABETIC MACULAR EDEMA IN THE NETHERLANDS
    Quist, S.
    Paulissen, J.
    Freriks, R. D.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S317 - S318
12345